解码肠道微生物群 - 妊娠期糖尿病链接:过去七年的见解
Luis Ricardo Balleza-Alejandri1, Emiliano Peña-Durán2, Alberto Beltrán-Ramírez3
1Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
Microorganisms
|June 27, 2024
概括
肠道微生物群失衡 (失生症) 与妊娠期糖尿病 (GD) 有关,并影响新陈代谢. 本综述强调了最近关于失生症,GD和潜在干预措施 (如饮食和益生菌) 的发现,以促进母婴健康.
科学领域:
- 微生物学 微生物学
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 人类微生物组对健康至关重要,影响新陈代谢和免疫力.
- 肠道微生物群失调与糖尿病和妊娠糖尿病 (GD) 等代谢障碍有关.
- 怀孕引起的微生物组变化可能会恶化葡萄糖不耐受,这是GD的标志.
研究的目的:
- 审查关于肠道微生物群失调和妊娠期糖尿病的最新文献 (过去7年).
- 探索失调症,GD,抗糖尿病药物代谢以及饮食和益生菌的作用之间的关联.
- 讨论病理生理机制,包括炎症和宿主微生物相互作用.
主要方法:
- 对过去七年内发表的研究进行了全面的文献综述.
- 对研究的分析,重点是肠道微生物群在妊娠糖尿病中的作用.
- 综合了关于微生物失生症,代谢变化和治疗干预措施的发现.
主要成果:
- 肠道失调有助于糖尿病的炎症和胰岛素抵抗.
- 怀孕期间的微生物组变化可能会加剧葡萄糖不耐受,增加GD风险.
- 饮食和益生菌显示出通过微生物调节来管理GD的干预措施的潜力.
结论:
- 肠道微生物群的健康对于预防和管理妊娠期糖尿病至关重要.
- 了解失生症机制为改善母婴健康结果提供了洞察力.
- 未来的研究应该专注于用于GD和相关代谢条件的微生物干预.
相关概念视频
Pathophysiology of Diabetes
918
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
918
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Anatomy of the Intestines
71.7K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.7K
What is Monogastric Digestion?
71.0K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.0K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Glucagon-like Receptor Agonists
313
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
313


